Waiv
5 known investors
Find your way into Waiv
Waiv develops AI-based diagnostic tests for precision oncology, using machine learning and foundation models to support biomarker discovery and multimodal diagnostic workflows. A spin-out of Owkin, it works with healthcare institutions and biopharma partners to bring clinically validated tests to patients.
Investors · 5
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AApr 2026
CRB Digital Health III (lead), Alpha Intelligence Capital, CRB Health Tech, Karista, OTB Ventures, Serena Data Ventures, SistaFund
Source ↗ - $33MraisedMar 2026 · 4 sources
Alpha Intelligence Capital (lead), OTB Ventures (lead), Karista, Serena Data Ventures, SistaFund
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Waiv do?
- Waiv develops AI-based diagnostic tests for precision oncology, using machine learning and foundation models to support biomarker discovery and multimodal diagnostic workflows. A spin-out of Owkin, it works with healthcare institutions and biopharma partners to bring clinically validated tests to patients.
- Who are Waiv's investors?
- Waiv's investors include Serena, Sista, Alpha Intelligence Capital, Karista, OTB Ventures.